Merck, Moderna share positive progress of potential skin cancer vaccine

  • 📰 FOX29philly
  • ⏱ Reading Time:
  • 10 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 51%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

A potential skin cancer vaccine being developed using the same technology behind COVID shots fared well in a small study, the drug companies said.

File Image - Close up detail of the bare skin on a man back with scattered moles and freckles. via Getty Images

That combination was compared with Keytruda alone in a mid-stage clinical trial of 157 patients. Patients received either the combination or Keytruda after surgery to remove the tumors.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Hell no

They can't find a way to harm more people

😂

Yeah, I’ll use sunscreen and get yearly skin checks. Btw, I’m a skin cancer survivor!

No thanks.

MRNA? Then obviously hell no. Who knows where those skin cancer proteins are headed.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 570. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Moderna, Merck cancer vaccine combo cuts melanoma recurrence by 44%A combination of Moderna Inc's melanoma vaccine and Merck & Co's immunotherapy Keytruda cut the risk of skin cancer's recurrence or death by 44% compared with Keytruda alone in a mid-stage trial. Kind of convenient and good for NO BID PATENT PROFITS, that one jab causes a huge health problem, which can be 'solved' by another set of jabs, eh?
Source: Reuters - 🏆 2. / 97 Read more »

Merck, Moderna detail potential skin cancer vaccine progressThe drugmakers said a combination of the vaccine and Merck’s immunotherapy Keytruda led to a statistically significant improvement in recurrence-free survival time in patients with phase three or four melanoma who had tumors removed in surgery.
Source: wsfa12news - 🏆 338. / 59 Read more »